Video

Cancer Survivors Should Discuss COVID-19 Risks with Their Health Care Providers

Expert Dr. Sara Hurvitz discusses why cancer survivors should discuss their risk factors during the COVID-19 pandemic with their healthcare providers.

The new coronavirus, also called COVID-19, is particularly concerning for patients with cancer. However, survivors, while not as immunocompromised as those in active treatment, should still discuss their risk factors with their physicians to determine what, if any, extra precautions they should take.

At the 2020 Miami Breast Cancer Conference® and Educated Patient Breast Cancer Summit, CURE® spoke with Dr. Sara Hurvitz, an associate professor of medicine at the University of California, Los Angeles, about what questions survivors should ask their medical teams to stay safe during the pandemic.

Transcription:

I don’t think that most patients who are survivors who have already been treated for their breast cancer and are not currently on chemotherapy or other therapies that lower the white (blood cell) count, they’re not necessarily at a higher risk of developing it than other patients.

But it’s important to talk to one’s oncologist and primary care physician to gauge, based on my age, based on other medical conditions that I have, or based on the medications that I’m taking, how do you gauge what my risk is, and what activities should I avoid, or what activities am I OK to do?

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of two doctors with text.
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.